Katarzyna Wiktorska

Warsaw University of Life Sciences - SGGW

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Beata Naumczuk

Institute of Organic Chemistry and Biochemistry

POLAND

View details

JERZY SITKOWSKI

Narodowy Instytut Leków

POLAND

View details

Maciej Chotkowski

University of Warsaw

POLAND

View details

Paweł Różanowski

Head of Department

Greater Poland Cancer Center

POLAND

View details

Magdalena Urbanowicz

National Medicines Institute

POLAND

View details

Piotr Kiełbasiński

Professor

Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences

POLAND

View details

Maciej Mazur

University of Warsaw

POLAND

View details

Joanna Wietrzyk

Lab. head

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences

POLAND

View details

Wojciech Bocian

National Medicines Institute

POLAND

View details

ewa izycka-swieszewska

Prof.

Medical University of Gdansk

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katarzyna Wiktorska

Research Interests

Explore related searches

Contact this professor

Articles (10)

Antitumor and antimetastatic effects of dietary sulforaphane in a triple-negative breast cancer models

An Organofluorine Isoselenocyanate Analogue of Sulforaphane Affects Antimetabolite 5-Fluorouracil’s Anticancer Activity: A Perspective for New Combinatory Therapy in Triple-Negative Breast Cancer

A tetrahydroacridine derivative and its conjugate with gold nanoparticles: promising agents for the treatment of Alzheimer's disease

Anticancer effect and safety of doxorubicin and nutraceutical sulforaphane liposomal formulation in triple-negative breast cancer (TNBC) animal model

An Organofluorine Isoselenocyanate Analogue of Sulforaphane Affects Antimetabolite 5-Fluorouracil's Anticancer Activity: A Perspective for New Combinatory Therapy in Triple-Negative Breast Cancer

Anticancer effect and safety of doxorubicin and nutraceutical sulforaphane liposomal formulation in triple-negative breast cancer (TNBC) animal model

Sulforaphane derivatives containing triazaphosphaadamantane (PTA) or o-carborane substituent

Antibody–Drug Conjugates in Uro-Oncology

Insight on the Interaction between the Camptothecin Derivative and DNA Oligomer Mimicking the Target of Topo I Inhibitors

Insight on the Interaction between the Camptothecin Derivative and DNA Oligomer Mimicking the Target of Topo I Inhibitors

Collaborators (10)

Beata Naumczuk

JERZY SITKOWSKI

Maciej Chotkowski

Paweł Różanowski

Magdalena Urbanowicz

Piotr Kiełbasiński

Maciej Mazur

Joanna Wietrzyk

Wojciech Bocian

ewa izycka-swieszewska

Make your next move.